Figure 1. H&E, 10x.	Figure 2. H&E, 20x.
Figure 3. H&E, 40x.	Figure 4. Loss of E-cadherin expression in invasive component (20x).
Figure 5. The cancer cells were diffusely positive for androgen receptor (AR), 10x.